Computational chemistry is on the cusp of a new era, in which physics-based models of molecular systems bring new and unexpected insights into drug discovery. With exascale computing power on the ...

Having an interdisciplinary team—one that includes not just experts in computational AI, but also experts in other aspects of drug discovery—will also remain a priority for investment ...

This leap in quantum computing has profound implications for startups, particularly those positioned well to tackle problems ...

Developing a new drug is a massive undertaking that can take 15 years and cost more than $2.5 billion dollars.

Ofer Haviv is the CEO and President of Evogene. Prior to this role, he served as the company’s COO and CFO from 2002 to 2004 ...

Infrastructure as a Service (IaaS) provides the raw computing power and storage capabilities critical for the compute-intensive nature of life sciences. Researchers can perform high-performance ...

Additionally, the ability to predict 3D structural changes in proteins opens up new possibilities for drug discovery and the repurposing of existing treatments. “By combining MR-SPI with AlphaFold3, ...

Despite the optimistic growth outlook, the AI for drug discovery and development market faces several challenges. These include the high costs associated with AI technology adoption, the need for ...

For years, scientists in the field of molecular dynamics have been squeezed in their research. Traditional simulations that ...

CD ComputaBio’s PROTAC drug development services are meticulously designed to streamline the discovery and optimization process. The company delivers best-in-class support across the entire PROTAC ...